Detailed information for compound 1804375

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 312.363 | Formula: C18H20N2O3
  • H donors: 1 H acceptors: 1 LogP: 3.92 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 1
  • SMILES: CO/N=C(\c1ccccc1Oc1cc(C)ccc1C)/C(=O)NC
  • InChi: 1S/C18H20N2O3/c1-12-9-10-13(2)16(11-12)23-15-8-6-5-7-14(15)17(20-22-4)18(21)19-3/h5-11H,1-4H3,(H,19,21)/b20-17+
  • InChiKey: YUPFDXACLVOSHJ-LVZFUZTISA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Plasmodium falciparum deoxyuridine 5'-triphosphate nucleotidohydrolase 0.0155 0.0766 0.5
Entamoeba histolytica thymidine kinase, putative 0.0511 0.5833 1
Brugia malayi dUTP diphosphatase 0.0155 0.0766 0.5
Trichomonas vaginalis thymidine kinase, putative 0.0511 0.5833 1
Schistosoma mansoni deoxyuridine 5'-triphosphate nucleotidohydrolase 0.0155 0.0766 0.5
Entamoeba histolytica deoxyuridine 5-triphosphate nucleotidohydrolase domain containing protein 0.0155 0.0766 0.1313
Toxoplasma gondii deoxyuridine 5'-triphosphate nucleotidohydrolase, putative 0.0155 0.0766 0.5
Trichomonas vaginalis thymidine kinase, putative 0.0511 0.5833 1
Echinococcus multilocularis neuropeptide receptor A26 0.0458 0.5084 0.4676
Trypanosoma cruzi thymidine kinase, putative 0.0511 0.5833 0.5
Trichomonas vaginalis thymidine kinase, putative 0.0511 0.5833 1
Entamoeba histolytica hypothetical protein 0.0155 0.0766 0.1313
Echinococcus granulosus neuropeptide s receptor 0.0458 0.5084 1
Echinococcus granulosus neuropeptide receptor A26 0.0458 0.5084 1
Entamoeba histolytica deoxyuridine 5-triphosphate nucleotidohydrolase domain containing protein 0.0155 0.0766 0.1313
Chlamydia trachomatis deoxyuridine 5'-triphosphate nucleotidohydrolase 0.0155 0.0766 0.5
Trypanosoma brucei thymidine kinase 0.0511 0.5833 0.5
Entamoeba histolytica deoxyuridine 5-triphosphate nucleotidohydrolase, mitochondrial precursor, putative 0.0155 0.0766 0.1313
Wolbachia endosymbiont of Brugia malayi dUTPase 0.0155 0.0766 0.5
Entamoeba histolytica deoxyuridine 5-triphosphate nucleotidohydrolase domain containing protein 0.0155 0.0766 0.1313
Trypanosoma cruzi thymidine kinase, putative 0.0511 0.5833 0.5
Echinococcus multilocularis neuropeptide s receptor 0.0458 0.5084 0.4676
Plasmodium vivax deoxyuridine 5'-triphosphate nucleotidohydrolase, putative 0.0155 0.0766 0.5
Entamoeba histolytica deoxyuridine 5-triphosphate nucleotidohydrolase, mitochondrial precursor, putative 0.0155 0.0766 0.1313
Entamoeba histolytica deoxyuridine 5-triphosphate nucleotidohydrolase domain containing protein 0.0155 0.0766 0.1313
Entamoeba histolytica hypothetical protein 0.0155 0.0766 0.1313
Giardia lamblia Thymidine kinase 0.0511 0.5833 0.5
Loa Loa (eye worm) dUTP diphosphatase 0.0155 0.0766 0.5
Treponema pallidum deoxyuridine 5'-triphosphate nucleotidohydrolase (dut) 0.0155 0.0766 0.5
Leishmania major thymidine kinase, putative 0.0511 0.5833 0.5

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.